Medprin Accounts Payable vs Short Term Investments Analysis

301033 Stock   43.00  0.18  0.42%   
Medprin Regenerative financial indicator trend analysis is infinitely more than just investigating Medprin Regenerative recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medprin Regenerative is a good investment. Please check the relationship between Medprin Regenerative Accounts Payable and its Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Short Term Investments

Accounts Payable vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medprin Regenerative Accounts Payable account and Short Term Investments. At this time, the significance of the direction appears to have strong relationship.
The correlation between Medprin Regenerative's Accounts Payable and Short Term Investments is 0.62. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Medprin Regenerative Medical, assuming nothing else is changed. The correlation between historical values of Medprin Regenerative's Accounts Payable and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Medprin Regenerative Medical are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Accounts Payable i.e., Medprin Regenerative's Accounts Payable and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.62
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Medprin Regenerative obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Medprin Regenerative are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Investments

Short Term Investments is an item under the current assets section of Medprin Regenerative balance sheet. It contains any investments Medprin Regenerative Medical undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Medprin Regenerative can easily liquidate in the marketplace.
Most indicators from Medprin Regenerative's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medprin Regenerative current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medprin Regenerative Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
As of January 10, 2025, Tax Provision is expected to decline to about 6.1 M. In addition to that, Selling General Administrative is expected to decline to about 57.7 M
 2022 2023 2024 2025 (projected)
Gross Profit164.0M189.3M217.7M149.6M
Total Revenue195.3M230.9M265.5M179.7M

Medprin Regenerative fundamental ratios Correlations

-0.890.941.00.950.880.010.980.890.820.980.620.940.95-0.960.971.00.730.980.250.980.97-0.130.3-0.860.97
-0.89-0.91-0.85-0.86-0.970.25-0.84-0.74-0.69-0.83-0.72-0.96-0.790.98-0.97-0.89-0.78-0.83-0.36-0.84-0.8-0.05-0.440.68-0.78
0.94-0.910.920.930.930.120.960.90.820.90.420.860.95-0.950.930.930.540.90.00.930.93-0.350.1-0.860.92
1.0-0.850.920.950.840.080.980.90.830.990.570.90.97-0.930.940.990.690.990.20.980.99-0.170.25-0.880.98
0.95-0.860.930.950.870.060.950.960.940.950.520.870.93-0.950.920.950.650.950.070.960.95-0.250.13-0.950.95
0.88-0.970.930.840.87-0.240.850.750.770.810.620.930.79-0.960.960.870.690.810.20.870.79-0.090.25-0.720.79
0.010.250.120.080.06-0.240.170.320.110.09-0.65-0.320.310.12-0.190.0-0.530.09-0.70.060.23-0.77-0.57-0.290.23
0.98-0.840.960.980.950.850.170.930.850.960.440.860.99-0.920.920.970.570.960.050.990.99-0.330.11-0.910.99
0.89-0.740.90.90.960.750.320.930.940.90.30.720.95-0.860.80.880.450.9-0.150.910.95-0.46-0.06-0.990.95
0.82-0.690.820.830.940.770.110.850.940.830.320.710.83-0.810.770.810.450.83-0.160.890.87-0.41-0.15-0.970.88
0.98-0.830.90.990.950.810.090.960.90.830.590.890.96-0.910.920.990.721.00.210.970.98-0.140.27-0.880.97
0.62-0.720.420.570.520.62-0.650.440.30.320.590.810.37-0.650.710.630.980.590.860.510.430.690.85-0.260.42
0.94-0.960.860.90.870.93-0.320.860.720.710.890.810.79-0.960.990.940.880.890.490.890.830.160.51-0.690.82
0.95-0.790.950.970.930.790.310.990.950.830.960.370.79-0.890.870.950.510.96-0.020.950.99-0.390.07-0.920.99
-0.960.98-0.95-0.93-0.95-0.960.12-0.92-0.86-0.81-0.91-0.65-0.96-0.89-0.99-0.95-0.74-0.91-0.26-0.92-0.90.08-0.330.82-0.89
0.97-0.970.930.940.920.96-0.190.920.80.770.920.710.990.87-0.990.970.80.920.350.930.890.00.4-0.770.88
1.0-0.890.930.990.950.870.00.970.880.810.990.630.940.95-0.950.970.750.990.270.970.97-0.10.33-0.850.96
0.73-0.780.540.690.650.69-0.530.570.450.450.720.980.880.51-0.740.80.750.720.780.630.580.570.79-0.410.57
0.98-0.830.90.990.950.810.090.960.90.831.00.590.890.96-0.910.920.990.720.210.970.98-0.140.27-0.880.97
0.25-0.360.00.20.070.2-0.70.05-0.15-0.160.210.860.49-0.02-0.260.350.270.780.210.10.050.910.960.180.03
0.98-0.840.930.980.960.870.060.990.910.890.970.510.890.95-0.920.930.970.630.970.10.97-0.260.12-0.910.98
0.97-0.80.930.990.950.790.230.990.950.870.980.430.830.99-0.90.890.970.580.980.050.97-0.320.11-0.931.0
-0.13-0.05-0.35-0.17-0.25-0.09-0.77-0.33-0.46-0.41-0.140.690.16-0.390.080.0-0.10.57-0.140.91-0.26-0.320.860.48-0.33
0.3-0.440.10.250.130.25-0.570.11-0.06-0.150.270.850.510.07-0.330.40.330.790.270.960.120.110.860.130.09
-0.860.68-0.86-0.88-0.95-0.72-0.29-0.91-0.99-0.97-0.88-0.26-0.69-0.920.82-0.77-0.85-0.41-0.880.18-0.91-0.930.480.13-0.94
0.97-0.780.920.980.950.790.230.990.950.880.970.420.820.99-0.890.880.960.570.970.030.981.0-0.330.09-0.94
Click cells to compare fundamentals

Medprin Regenerative Account Relationship Matchups

Medprin Regenerative fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets455.3M746.8M744.9M787.0M905.0M676.3M
Other Current Liab699.4K452.1K608.6K809.4K728.5K657.1K
Total Current Liabilities58.1M54.2M81.8M68.1M78.3M65.0M
Total Stockholder Equity334.4M572.3M602.6M635.9M731.2M537.7M
Retained Earnings21.7M63.2M89.6M114.0M131.1M137.7M
Accounts Payable36.6M32.7M32.7M31.9M36.7M33.9M
Cash11.7M10.4M45.0M26.7M30.7M26.9M
Non Current Assets Total202.8M329.6M506.7M517.3M594.8M368.2M
Non Currrent Assets Other655.2K12.1M58.0M55.2M63.5M66.7M
Net Receivables7.7M5.3M10.4M18.1M20.8M21.8M
Short Term Investments199.3M375.6M147.1M192.8M221.7M234.9M
Non Current Liabilities Total59.1M116.7M60.6M83.0M95.4M71.2M
Inventory16.5M21.2M29.4M26.2M30.1M24.0M
Other Current Assets6.8M642.3K462.4K70.1K63.1K60.0K
Total Liab117.3M170.9M142.3M151.1M173.8M136.2M
Net Invested Capital381.9M673.9M652.9M682.3M784.6M591.8M
Total Current Assets252.6M417.1M238.2M269.7M310.2M308.1M
Net Working Capital194.4M363.0M156.5M201.6M181.4M176.8M
Intangible Assets62.9M76.2M82.8M94.2M108.4M80.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Medprin Stock

Balance Sheet is a snapshot of the financial position of Medprin Regenerative at a specified time, usually calculated after every quarter, six months, or one year. Medprin Regenerative Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medprin Regenerative and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medprin currently owns. An asset can also be divided into two categories, current and non-current.